Prosecution Insights
Last updated: April 19, 2026
Application No. 18/268,476

MICROCARRIER FOR CELL CULTURE AND CELL CULTURE METHOD

Non-Final OA §103
Filed
Jun 20, 2023
Examiner
HEINCER, LIAM J
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Sekisui Chemical Co. Ltd.
OA Round
1 (Non-Final)
56%
Grant Probability
Moderate
1-2
OA Rounds
3y 3m
To Grant
81%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allow Rate
783 granted / 1412 resolved
-9.5% vs TC avg
Strong +26% interview lift
Without
With
+25.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
89 currently pending
Career history
1501
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
49.8%
+9.8% vs TC avg
§102
22.4%
-17.6% vs TC avg
§112
14.4%
-25.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1412 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of group I, claims 1-9, in the reply filed on February 13, 2026 is acknowledged. Claim 10 is withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on February 13, 2026. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-9 are rejected under 35 U.S.C. 103 as being unpatentable over McCarthy et al. (US 2011/0027889) in view of Haneda et al. (WO 2019/131978). Note: US Pat. 12,180,450 is being used as an English language alternative for WO 2019/131978. Considering Claims 1, 3, and 4: McCarthy et al. teaches a microcarrier for culturing cells comprising a base particle (¶0047) and a coating layer on the base particle that can be a polyvinyl alcohol (¶0049), where a polypeptide is conjugated to the coating (¶0009), where the microcarrier has an average particle size of 20 to 1000 microns and a geometric size distribution of 1 to 1.4/coefficient of variation of 0 to 40% (¶0044). McCarthy et al. does not teach the coating as being a polyvinyl acetal. However, Haneda et al. teaches a coating for cell cultures comprising a polyvinyl butyral (7:25-61) grafted with amine and/or amide groups (11:4-42). McCarthy et al. and Haneda et al. are analogous art as they are concerned with the same field of endeavor, namely cell culture coatings. It would have been obvious to a person of ordinary skill in the art to have used the polyvinyl acetal of Haneda et al. as the coating polymer of McCarthy et al., and the motivation to do so would have been, as Haneda et al. suggests, to increase the strength of the polyvinyl alcohol polymer of McCarthy et al. (7:4-21). Considering Claim 2: The Office realizes that all of the claimed effects or physical properties are not positively stated by the reference(s). However, the reference(s) teaches all of the claimed ingredients, in the claimed amounts, and teaches the composition as being made by a substantially similar process. The original specification does not provide any disclosure on how to obtain the claimed properties outside the components of the composition itself. Therefore, the claimed effects and physical properties, i.e. the water absorption, would necessarily arise from a composition with all the claimed ingredients in the claimed amounts. "Products of identical chemical composition can not have mutually exclusive properties." In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. If it is the applicant’s position that this would not be the case: (1) evidence would need to be provided to support the applicant’s position; and (2) it would be the Office’s position that the application contains inadequate disclosure that there is no teaching enabling a person of ordinary skill in the art to obtain the claimed properties with only the claimed ingredients, absent undue experimentation. Considering Claim 5: McCarthy et al. teaches the density of the microcarrier as being 1.01 to 1.10 g/cm3 (¶0043). Considering Claims 6-8: McCarthy et al. teaches the base particle as being a polymethylmethacrylate (¶0047). Considering Claim 9: McCarthy et al. teaches the polypeptide as having cell adhesion activity (¶0091). Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to LIAM J HEINCER whose telephone number is (571)270-3297. The examiner can normally be reached M-F 7:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LIAM J HEINCER/Primary Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

Jun 20, 2023
Application Filed
Mar 19, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600849
Super Absorbent Polymer Film and Preparation Method Thereof
2y 5m to grant Granted Apr 14, 2026
Patent 12600667
GLASS SHEET FOR CHEMICAL STRENGTHENING, MANUFACTURING METHOD OF STRENGTHENED GLASS SHEET, AND GLASS SHEET
2y 5m to grant Granted Apr 14, 2026
Patent 12595320
METHOD OF CONTROLLING ALPHA-OLEFIN CONDENSATION IN ABSORPTION MEDIA DURING POLYOLEFIN PRODUCTION
2y 5m to grant Granted Apr 07, 2026
Patent 12589377
ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION
2y 5m to grant Granted Mar 31, 2026
Patent 12590114
METHOD OF MAKING A BINDER COMPOSITION, AND BINDER COMPOSITION
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
56%
Grant Probability
81%
With Interview (+25.7%)
3y 3m
Median Time to Grant
Low
PTA Risk
Based on 1412 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month